Total Payments
$568.20
2022 Payments
$14.10
Companies
9
Transactions
29
Medicare Patients
932
Medicare Billing
$105,223
Payment Breakdown by Category
Food & Beverage$568.20 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $568.20 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $370.75 | 15 | $0 (2019) |
| Shire North American Group Inc | $53.92 | 4 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $36.87 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $28.53 | 2 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $17.10 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.74 | 1 | $0 (2019) |
| Romark Laboratories, LC | $15.65 | 1 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $15.54 | 1 | $0 (2018) |
| Merck Sharp & Dohme LLC | $14.10 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.10 | 1 | Merck Sharp & Dohme LLC ($14.10) |
| 2019 | $240.87 | 8 | AbbVie, Inc. ($206.01) |
| 2018 | $143.64 | 9 | AbbVie, Inc. ($79.70) |
| 2017 | $169.59 | 11 | AbbVie, Inc. ($85.04) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2022 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Immunology | ||||||
| 11/13/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $112.52 | General |
| 10/10/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Immunology | ||||||
| 10/08/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Immunology | ||||||
| 02/28/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Immunology | ||||||
| 01/28/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Immunology | ||||||
| 01/25/2019 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Lower GI | ||||||
| 09/28/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Immunology | ||||||
| 08/06/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/04/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Endocrinology | ||||||
| 05/18/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/06/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/14/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Immunology | ||||||
| 03/02/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology | ||||||
| 02/10/2018 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DELZICOL | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Gastroenterology | ||||||
| 01/05/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
| 12/15/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Endocrinology | ||||||
| 11/10/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology | ||||||
| 11/03/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Gastroenterology | ||||||
| 09/30/2017 | Takeda Pharmaceuticals America, Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Lower GI | ||||||
| 08/07/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Immunology | ||||||
| 05/11/2017 | Romark Laboratories, LC | Alinia Tablets 500mg 30 count bottle (Drug), Alinia for Oral Suspension, Alinia Tablets 500mg 12 count bottle | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Gastroenterology | ||||||
| 05/06/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 166 | 175 | $61,817 | $17,785 |
| 2022 | 4 | 157 | 165 | $54,445 | $17,790 |
| 2021 | 13 | 386 | 409 | $146,451 | $43,858 |
| 2020 | 6 | 223 | 249 | $75,505 | $25,790 |
Total Patients
932
Total Services
998
Medicare Billing
$105,223
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 76 | $15,580 | $7,948 | 51.0% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 11 | 11 | $9,075 | $2,412 | 26.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $7,150 | $1,838 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $3,612 | $1,673 | 46.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 17 | $8,500 | $1,599 | 18.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $10,000 | $1,467 | 14.7% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 12 | 12 | $7,200 | $587.91 | 8.2% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 12 | 14 | $700.00 | $259.42 | 37.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 93 | 99 | $20,295 | $10,881 | 53.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 23 | $12,650 | $3,381 | 26.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $13,500 | $2,121 | 15.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $8,000 | $1,407 | 17.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 140 | 149 | $30,545 | $16,538 | 54.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 26 | 26 | $19,500 | $5,197 | 26.7% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 32 | 35 | $19,250 | $5,184 | 26.9% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 43 | 45 | $22,500 | $3,379 | 15.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 31 | 31 | $15,500 | $2,780 | 17.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 17 | 17 | $11,475 | $2,231 | 19.4% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope via mouth | Facility | 2021 | 13 | 15 | $12,375 | $2,133 | 17.2% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 13 | 13 | $5,213 | $2,129 | 40.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $3,612 | $1,974 | 54.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 13 | $1,391 | $767.39 | 55.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 24 | $1,440 | $756.24 | 52.5% |
| 74328 | Radiological supervision and interpretation of insertion of catheter into biliary duct using an endoscope | Facility | 2021 | 14 | 18 | $900.00 | $424.80 | 47.2% |
| 43450 | Dilation of esophagus unguided | Facility | 2021 | 11 | 11 | $2,750 | $364.87 | 13.3% |
About Dr. Philip Opalenski, MD
Dr. Philip Opalenski, MD is a Gastroenterology healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619062411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Opalenski, MD has received a total of $568.20 in payments from pharmaceutical and medical device companies, with $14.10 received in 2022. These payments were reported across 29 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($568.20).
As a Medicare-enrolled provider, Opalenski has provided services to 932 Medicare beneficiaries, totaling 998 services with total Medicare billing of $105,223. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Cranston, RI
- Active Since 10/04/2006
- Last Updated 01/20/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619062411
Products in Payments
- Humira (Biological) $211.05
- GATTEX (Drug) $53.92
- Creon (Drug) $47.18
- STELARA (Biological) $28.53
- Entyvio (Biological) $27.86
- Dexilant (Drug) $24.75
- Trulance (Drug) $17.10
- Alinia Tablets 500mg 30 count bottle (Drug) $15.65
- LINZESS (Drug) $15.54
- BRIDION (Drug) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cranston
Morris Elevado, M.d, M.D
Gastroenterology — Payments: $327,895
Gastroenterology $327,895
Colin Woodard, Do, DO
Gastroenterology — Payments: $8,820
Gastroenterology $8,820
Thomas Mcgreen, M.d, M.D
Gastroenterology — Payments: $7,672
Gastroenterology $7,672
Robert Wolfgang, D.o, D.O
Gastroenterology — Payments: $6,692
Gastroenterology $6,692
George Powers, M.d, M.D
Gastroenterology — Payments: $1,319
Gastroenterology $1,319
Paul Roderick, M.d, M.D
Gastroenterology — Payments: $1,317
Gastroenterology $1,317